CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis
Introduction Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently, CXCL9 has been considered an inflammatory chemokine associated with the pathogenesis of CVD. Here, we evaluated t...
Saved in:
Published in | Clinical rheumatology Vol. 43; no. 1; pp. 137 - 145 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently, CXCL9 has been considered an inflammatory chemokine associated with the pathogenesis of CVD. Here, we evaluated the association of plasma CXCL9 with well-established cardiac biomarkers, including HS-CRP (High sensitivity C-reactive protein) and NT-ProBNP (N-terminal pro-B-type natriuretic peptide), in newly diagnosed and under-treatment RA patients.
Methods
Thirty newly diagnosed patients, 30 under-treatment RA patients, and 30 healthy subjects were recruited. The plasma concentration of CXCL9 and NT-ProBNP was measured using the ELISA method. The HS-CRP levels was measured in plasma samples using latex-enhanced immunoturbidimetric test.
Results
We found increased plasma levels of CXCL9, HS-CRP, and NT-proBNP in RA patients compared to healthy subjects, besides that the concentration of CXCL9, HS-CRP, and NT-ProBNP showed elevated levels in newly diagnosed RA patients compared to under-treatment group. The mean plasma concentration of CXCL9, NT-proBNP, and HS-CRP were statistically different among healthy subjects, newly diagnosed, and under-treatment RA patients (
p
< 0.001,
p
= 0.016, and
p
< 0.001, respectively). We also found a significant positive correlation between CXCL9 and DAS-28 (
p
= 0.0005,
r
= 0.436) in the patients’ group (new-case + under-treatment). There was a significantly positive correlation between CXCL9 and NT-proBNP in newly diagnosed and under-treatment patients (
p
= 0.020,
r
= 0.424;
p
< 0.0001,
r
= 0.853, respectively). In the patient’s group (new-case + under-treatment), there was a significantly positive correlation between CXCL9 with NT-proBNP (
p
< 0.001,
r
= 0.703) and CXCL9 with HS-CRP (
p
= 0.015,
r
= 0.313).
Conclusion
CXCL9 correlates significantly with well-established cardiovascular biomarkers, including HS-CRP and NT-ProBNP in RA patients.
Key Points
•
CXCL9 is an inflammatory marker in RA
.
•
CXCL9 has correlated with DAS-28
.
•
There is a strong correlation between CXCL9 with NT-proBNP and HS-CRP
. |
---|---|
AbstractList | INTRODUCTIONCardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently, CXCL9 has been considered an inflammatory chemokine associated with the pathogenesis of CVD. Here, we evaluated the association of plasma CXCL9 with well-established cardiac biomarkers, including HS-CRP (High sensitivity C-reactive protein) and NT-ProBNP (N-terminal pro-B-type natriuretic peptide), in newly diagnosed and under-treatment RA patients.METHODSThirty newly diagnosed patients, 30 under-treatment RA patients, and 30 healthy subjects were recruited. The plasma concentration of CXCL9 and NT-ProBNP was measured using the ELISA method. The HS-CRP levels was measured in plasma samples using latex-enhanced immunoturbidimetric test.RESULTSWe found increased plasma levels of CXCL9, HS-CRP, and NT-proBNP in RA patients compared to healthy subjects, besides that the concentration of CXCL9, HS-CRP, and NT-ProBNP showed elevated levels in newly diagnosed RA patients compared to under-treatment group. The mean plasma concentration of CXCL9, NT-proBNP, and HS-CRP were statistically different among healthy subjects, newly diagnosed, and under-treatment RA patients (p < 0.001, p = 0.016, and p < 0.001, respectively). We also found a significant positive correlation between CXCL9 and DAS-28 (p = 0.0005, r = 0.436) in the patients' group (new-case + under-treatment). There was a significantly positive correlation between CXCL9 and NT-proBNP in newly diagnosed and under-treatment patients (p = 0.020, r = 0.424; p < 0.0001, r = 0.853, respectively). In the patient's group (new-case + under-treatment), there was a significantly positive correlation between CXCL9 with NT-proBNP (p < 0.001, r = 0.703) and CXCL9 with HS-CRP (p = 0.015, r = 0.313).CONCLUSIONCXCL9 correlates significantly with well-established cardiovascular biomarkers, including HS-CRP and NT-ProBNP in RA patients. Key Points • CXCL9 is an inflammatory marker in RA. • CXCL9 has correlated with DAS-28. • There is a strong correlation between CXCL9 with NT-proBNP and HS-CRP. Introduction Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently, CXCL9 has been considered an inflammatory chemokine associated with the pathogenesis of CVD. Here, we evaluated the association of plasma CXCL9 with well-established cardiac biomarkers, including HS-CRP (High sensitivity C-reactive protein) and NT-ProBNP (N-terminal pro-B-type natriuretic peptide), in newly diagnosed and under-treatment RA patients. Methods Thirty newly diagnosed patients, 30 under-treatment RA patients, and 30 healthy subjects were recruited. The plasma concentration of CXCL9 and NT-ProBNP was measured using the ELISA method. The HS-CRP levels was measured in plasma samples using latex-enhanced immunoturbidimetric test. Results We found increased plasma levels of CXCL9, HS-CRP, and NT-proBNP in RA patients compared to healthy subjects, besides that the concentration of CXCL9, HS-CRP, and NT-ProBNP showed elevated levels in newly diagnosed RA patients compared to under-treatment group. The mean plasma concentration of CXCL9, NT-proBNP, and HS-CRP were statistically different among healthy subjects, newly diagnosed, and under-treatment RA patients ( p < 0.001, p = 0.016, and p < 0.001, respectively). We also found a significant positive correlation between CXCL9 and DAS-28 ( p = 0.0005, r = 0.436) in the patients’ group (new-case + under-treatment). There was a significantly positive correlation between CXCL9 and NT-proBNP in newly diagnosed and under-treatment patients ( p = 0.020, r = 0.424; p < 0.0001, r = 0.853, respectively). In the patient’s group (new-case + under-treatment), there was a significantly positive correlation between CXCL9 with NT-proBNP ( p < 0.001, r = 0.703) and CXCL9 with HS-CRP ( p = 0.015, r = 0.313). Conclusion CXCL9 correlates significantly with well-established cardiovascular biomarkers, including HS-CRP and NT-ProBNP in RA patients. Key Points • CXCL9 is an inflammatory marker in RA . • CXCL9 has correlated with DAS-28 . • There is a strong correlation between CXCL9 with NT-proBNP and HS-CRP . Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently, CXCL9 has been considered an inflammatory chemokine associated with the pathogenesis of CVD. Here, we evaluated the association of plasma CXCL9 with well-established cardiac biomarkers, including HS-CRP (High sensitivity C-reactive protein) and NT-ProBNP (N-terminal pro-B-type natriuretic peptide), in newly diagnosed and under-treatment RA patients. Thirty newly diagnosed patients, 30 under-treatment RA patients, and 30 healthy subjects were recruited. The plasma concentration of CXCL9 and NT-ProBNP was measured using the ELISA method. The HS-CRP levels was measured in plasma samples using latex-enhanced immunoturbidimetric test. We found increased plasma levels of CXCL9, HS-CRP, and NT-proBNP in RA patients compared to healthy subjects, besides that the concentration of CXCL9, HS-CRP, and NT-ProBNP showed elevated levels in newly diagnosed RA patients compared to under-treatment group. The mean plasma concentration of CXCL9, NT-proBNP, and HS-CRP were statistically different among healthy subjects, newly diagnosed, and under-treatment RA patients (p < 0.001, p = 0.016, and p < 0.001, respectively). We also found a significant positive correlation between CXCL9 and DAS-28 (p = 0.0005, r = 0.436) in the patients' group (new-case + under-treatment). There was a significantly positive correlation between CXCL9 and NT-proBNP in newly diagnosed and under-treatment patients (p = 0.020, r = 0.424; p < 0.0001, r = 0.853, respectively). In the patient's group (new-case + under-treatment), there was a significantly positive correlation between CXCL9 with NT-proBNP (p < 0.001, r = 0.703) and CXCL9 with HS-CRP (p = 0.015, r = 0.313). CXCL9 correlates significantly with well-established cardiovascular biomarkers, including HS-CRP and NT-ProBNP in RA patients. Key Points • CXCL9 is an inflammatory marker in RA. • CXCL9 has correlated with DAS-28. • There is a strong correlation between CXCL9 with NT-proBNP and HS-CRP. |
Author | Roghani, Seyed Askar Shamsi, Afsaneh Soufivand, Parviz Taghadosi, Mahdi Pournazari, Mehran Khoobbakht, Fatemeh Bahrehmand, Fariborz |
Author_xml | – sequence: 1 givenname: Afsaneh orcidid: 0000-0002-5945-2381 surname: Shamsi fullname: Shamsi, Afsaneh organization: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences – sequence: 2 givenname: Seyed Askar orcidid: 0000-0003-0758-0653 surname: Roghani fullname: Roghani, Seyed Askar organization: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences – sequence: 3 givenname: Parviz orcidid: 0000-0001-5517-791X surname: Soufivand fullname: Soufivand, Parviz organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences – sequence: 4 givenname: Mehran orcidid: 0000-0003-3542-3049 surname: Pournazari fullname: Pournazari, Mehran organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences – sequence: 5 givenname: Fatemeh orcidid: 0009-0007-3012-0168 surname: Khoobbakht fullname: Khoobbakht, Fatemeh organization: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences – sequence: 6 givenname: Fariborz orcidid: 0000-0003-3866-6847 surname: Bahrehmand fullname: Bahrehmand, Fariborz organization: Medical Biology Research Center, Kermanshah University of Medical Sciences – sequence: 7 givenname: Mahdi orcidid: 0000-0002-3516-0130 surname: Taghadosi fullname: Taghadosi, Mahdi email: mtaghad@gmail.com organization: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38006573$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kTtvFDEUhS2UiGwCf4ACWaKhiINf40cJqwSQVoEiSHSWZ-YOcTJjB3sGtE1-O95sAImCxrbk8137nHOMDmKKgNALRs8YpfpNqavShHJBqDJcke0TtGJSSGKttAdoRbWmRDBrjtBxKTeUUm4se4qOhKlko8UK3a-_rjcW-9jjyytyl9O7y8-n2OOYZt-OgMcQb3EL80-AiEMcRj9Nfk55iyfow-70wHY-9yH98KVbRp9xHwr4ArgNafL5FnJFcb6GZceGHvs8X-cwh_IMHQ5-LPD8cT9BXy7Or9YfyObT-4_rtxvSCd3MRNp2MMZwEMJrrZRU0uhGGyMk66BjzTDULIT2TKm-MYpV494a2_AGFKvUCXq9n1sdfl-gzG4KpYNx9BHSUlzNRRjJhNZV-uof6U1acqy_c9wypiTnZqfie1WXUykZBneXQ_W6dYy6XTtu346r7biHdty2Qi8fRy9tje8P8ruOKhB7QalX8Rvkv2__Z-wvr-ibtg |
CitedBy_id | crossref_primary_10_3390_cells13110915 |
Cites_doi | 10.1038/s43587-021-00082-y 10.1136/bmjopen-2018-026030 10.1136/rmdopen-2019-001032 10.3389/fimmu.2018.00754 10.1136/annrheumdis-2016-eular.4903 10.3390/cells9040880 10.1007/s40744-019-00189-0 10.1016/j.aller.2013.11.003 10.17116/terarkh201688519-26 10.1007/s10067-017-3961-6 10.1007/s00296-020-04731-0 10.1111/j.1541-9215.2003.02109.x 10.1371/journal.pone.0253793 10.1038/s41584-020-0428-y 10.3390/diagnostics12010182 10.3899/jrheum.090769 10.1016/j.atherosclerosis.2017.02.003 10.1371/journal.pone.0006242 10.1016/j.autrev.2021.102776 10.1161/ATVBAHA.118.312037 10.1016/j.chest.2021.07.265 10.3390/life11101042 10.1016/j.semarthrit.2020.11.005 10.1038/s41598-021-92488-2 10.1016/j.ijcha.2020.100553 10.1038/s41584-019-0256-0 10.1186/s13075-017-1224-1 10.1056/NEJMra2103726 10.1002/clc.23760 10.1155/2017/5858315 10.1177/11795441211028751 10.1038/s41440-020-0483-4 10.3389/fphar.2021.765768 10.1093/eurheartj/ehz745.0836 10.1093/rheumatology/kes279 10.32873/unmc.dc.gmerj.4.1.021 10.21203/rs.3.rs-2868920/v1 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR). |
Copyright_xml | – notice: The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR). |
DBID | NPM AAYXX CITATION 7T5 H94 K9. 7X8 |
DOI | 10.1007/s10067-023-06826-y |
DatabaseName | PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1434-9949 |
EndPage | 145 |
ExternalDocumentID | 10_1007_s10067_023_06826_y 38006573 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHVUH AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z5O Z7U Z7V Z7X Z81 Z82 Z83 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX ~KM AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV H13 NPM AAYXX CITATION 7T5 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c375t-49bf8882e33a7766464875788341cec15ff10037a166d5861770a989525e61e33 |
IEDL.DBID | AGYKE |
ISSN | 0770-3198 |
IngestDate | Sat Aug 17 02:50:30 EDT 2024 Thu Oct 10 22:11:31 EDT 2024 Thu Sep 12 17:15:21 EDT 2024 Wed Oct 23 09:55:24 EDT 2024 Tue Jan 09 01:19:01 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | CXCL9 NT-proBNP HS-CRP Cardiovascular Rheumatoid arthritis DAS-28 |
Language | English |
License | 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-49bf8882e33a7766464875788341cec15ff10037a166d5861770a989525e61e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5945-2381 0000-0003-3866-6847 0000-0003-0758-0653 0000-0002-3516-0130 0000-0003-3542-3049 0009-0007-3012-0168 0000-0001-5517-791X |
PMID | 38006573 |
PQID | 2911642287 |
PQPubID | 326351 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2893841377 proquest_journals_2911642287 crossref_primary_10_1007_s10067_023_06826_y pubmed_primary_38006573 springer_journals_10_1007_s10067_023_06826_y |
PublicationCentury | 2000 |
PublicationDate | 1-2024 2024-Jan 2024-01-00 20240101 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – year: 2024 text: 1-2024 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Germany – name: Heidelberg |
PublicationSubtitle | Journal of the International League of Associations for Rheumatology |
PublicationTitle | Clinical rheumatology |
PublicationTitleAbbrev | Clin Rheumatol |
PublicationTitleAlternate | Clin Rheumatol |
PublicationYear | 2024 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Bellagambi (CR25) 2021; 11 Dessein, Joffe, Stanwix (CR29) 2004; 31 Li (CR31) 2017; 259 Nguyen (CR37) 2021; 16 Kirillova (CR36) 2016; 88 Semb (CR4) 2020; 16 CR17 CR38 CR15 Torres, Ridker (CR22) 2003; 1 Pandya (CR27) 2017; 19 CR11 Paparo (CR16) 2019; 170 CR10 Ferguson (CR13) 2019; 15 CR32 Kuan (CR26) 2010; 37 Lin, Anzaghe, Schülke (CR2) 2020; 9 Rongen (CR40) 2018; 37 Clearfield (CR33) 2005; 105 Shrivastava (CR28) 2015; 43 Rudolf (CR23) 2020; 29 Noels, Weber, Koenen (CR12) 2019; 39 Frade-Sosa (CR18) 2022; 12 Graf (CR21) 2009; 4 CR7 Figus (CR6) 2021; 20 Kondrateva (CR35) 2021; 160 Sayed (CR14) 2021; 1 Rezuş (CR8) 2021; 11 Sproston, Ashworth (CR19) 2018; 9 CR20 CR42 CR41 Almutairi (CR3) 2021; 41 DeMizio, Geraldino-Pardilla (CR5) 2020; 7 Pope, Choy (CR30) 2021; 51 Gravallese, Firestein (CR1) 2023; 388 Kirillova (CR39) 2016; 75 Błyszczuk, Szekanecz (CR9) 2020; 6 Nah (CR24) 2019; 9 Zhao (CR34) 2022; 45 DJ DeMizio (6826_CR5) 2020; 7 6826_CR11 NR Sproston (6826_CR19) 2018; 9 MB Clearfield (6826_CR33) 2005; 105 FA Figus (6826_CR6) 2021; 20 H Noels (6826_CR12) 2019; 39 6826_CR15 6826_CR38 Y-J Lin (6826_CR2) 2020; 9 6826_CR17 PH Dessein (6826_CR29) 2004; 31 JL Torres (6826_CR22) 2003; 1 B Frade-Sosa (6826_CR18) 2022; 12 JM Pandya (6826_CR27) 2017; 19 I Kirillova (6826_CR36) 2016; 88 6826_CR10 6826_CR32 K Almutairi (6826_CR3) 2021; 41 WP Kuan (6826_CR26) 2010; 37 E Rezuş (6826_CR8) 2021; 11 J Graf (6826_CR21) 2009; 4 E-H Nah (6826_CR24) 2019; 9 EM Gravallese (6826_CR1) 2023; 388 6826_CR41 N Sayed (6826_CR14) 2021; 1 6826_CR20 FG Bellagambi (6826_CR25) 2021; 11 Y Li (6826_CR31) 2017; 259 TH Nguyen (6826_CR37) 2021; 16 6826_CR42 S Paparo (6826_CR16) 2019; 170 IG Kirillova (6826_CR39) 2016; 75 AG Semb (6826_CR4) 2020; 16 LD Ferguson (6826_CR13) 2019; 15 JE Pope (6826_CR30) 2021; 51 H Rudolf (6826_CR23) 2020; 29 GA Rongen (6826_CR40) 2018; 37 X Zhao (6826_CR34) 2022; 45 P Błyszczuk (6826_CR9) 2020; 6 L Kondrateva (6826_CR35) 2021; 160 6826_CR7 AK Shrivastava (6826_CR28) 2015; 43 |
References_xml | – volume: 1 start-page: 598 issue: 7 year: 2021 end-page: 615 ident: CR14 article-title: An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging publication-title: Nature aging doi: 10.1038/s43587-021-00082-y contributor: fullname: Sayed – volume: 9 issue: 4 year: 2019 ident: CR24 article-title: Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026030 contributor: fullname: Nah – volume: 105 start-page: 409 issue: 9 year: 2005 end-page: 416 ident: CR33 article-title: C-reactive protein: a new risk assessment tool for cardiovascular disease publication-title: J Am Osteopath Assoc contributor: fullname: Clearfield – volume: 6 issue: 1 year: 2020 ident: CR9 article-title: Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis publication-title: RMD Open doi: 10.1136/rmdopen-2019-001032 contributor: fullname: Szekanecz – ident: CR10 – volume: 9 start-page: 754 year: 2018 ident: CR19 article-title: Role of C-reactive protein at sites of inflammation and infection publication-title: Front Immunol doi: 10.3389/fimmu.2018.00754 contributor: fullname: Ashworth – volume: 75 start-page: 706 issue: Suppl 2 year: 2016 end-page: 706 ident: CR39 article-title: SAT0113 implementation of the treat-to-target strategy leads to dramatically reduction of n-terminal pro-brain natriuretic peptide level in patients with early rheumatoid arthritis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-eular.4903 contributor: fullname: Kirillova – volume: 9 start-page: 880 issue: 4 year: 2020 ident: CR2 article-title: Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis publication-title: Cells doi: 10.3390/cells9040880 contributor: fullname: Schülke – volume: 7 start-page: 19 year: 2020 end-page: 33 ident: CR5 article-title: Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis publication-title: Rheumatology and therapy doi: 10.1007/s40744-019-00189-0 contributor: fullname: Geraldino-Pardilla – volume: 43 start-page: 81 issue: 1 year: 2015 end-page: 87 ident: CR28 article-title: Inflammatory markers in patients with rheumatoid arthritis publication-title: Allergol Immunopathol doi: 10.1016/j.aller.2013.11.003 contributor: fullname: Shrivastava – volume: 88 start-page: 19 issue: 5 year: 2016 end-page: 26 ident: CR36 article-title: N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs publication-title: Ter Arkh doi: 10.17116/terarkh201688519-26 contributor: fullname: Kirillova – volume: 31 start-page: 1095 issue: 6 year: 2004 end-page: 1097 ident: CR29 article-title: High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis publication-title: J Rheumatol contributor: fullname: Stanwix – volume: 37 start-page: 909 year: 2018 end-page: 916 ident: CR40 article-title: Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs publication-title: Clin Rheumatol doi: 10.1007/s10067-017-3961-6 contributor: fullname: Rongen – ident: CR42 – volume: 41 start-page: 863 issue: 5 year: 2021 end-page: 877 ident: CR3 article-title: The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review publication-title: Rheumatol Int doi: 10.1007/s00296-020-04731-0 contributor: fullname: Almutairi – volume: 1 start-page: 207 issue: 3 year: 2003 end-page: 211 ident: CR22 article-title: High sensitivity C-reactive protein in clinical practice publication-title: Am Heart Hosp J doi: 10.1111/j.1541-9215.2003.02109.x contributor: fullname: Ridker – volume: 16 issue: 6 year: 2021 ident: CR37 article-title: Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis publication-title: PLoS ONE doi: 10.1371/journal.pone.0253793 contributor: fullname: Nguyen – volume: 16 start-page: 361 issue: 7 year: 2020 end-page: 379 ident: CR4 article-title: Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-020-0428-y contributor: fullname: Semb – volume: 12 start-page: 182 issue: 1 year: 2022 ident: CR18 article-title: High sensitivity c reactive protein in patients with rheumatoid arthritis treated with antibodies against IL-6 or Jak inhibitors: a clinical and ultrasonographic study publication-title: Diagnostics doi: 10.3390/diagnostics12010182 contributor: fullname: Frade-Sosa – volume: 170 start-page: e472 issue: 6 year: 2019 end-page: 477 ident: CR16 article-title: Rheumatoid arthritis and the Th1 chemokine MIG publication-title: Clin Ter contributor: fullname: Paparo – ident: CR15 – ident: CR38 – ident: CR17 – volume: 37 start-page: 257 issue: 2 year: 2010 end-page: 264 ident: CR26 article-title: CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis publication-title: J Rheumatol doi: 10.3899/jrheum.090769 contributor: fullname: Kuan – ident: CR11 – volume: 259 start-page: 75 year: 2017 end-page: 82 ident: CR31 article-title: Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.02.003 contributor: fullname: Li – volume: 4 issue: 7 year: 2009 ident: CR21 article-title: Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis publication-title: PLoS ONE doi: 10.1371/journal.pone.0006242 contributor: fullname: Graf – ident: CR32 – volume: 20 issue: 4 year: 2021 ident: CR6 article-title: Rheumatoid arthritis: extra-articular manifestations and comorbidities publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2021.102776 contributor: fullname: Figus – volume: 39 start-page: 583 issue: 4 year: 2019 end-page: 592 ident: CR12 article-title: Chemokines as therapeutic targets in cardiovascular disease: the road behind, the road ahead publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.118.312037 contributor: fullname: Koenen – volume: 160 start-page: A257 issue: 4 year: 2021 ident: CR35 article-title: N-terminal pro-brain natriuretic peptide levels in patients with early and long-term rheumatoid arthritis publication-title: Chest doi: 10.1016/j.chest.2021.07.265 contributor: fullname: Kondrateva – volume: 11 start-page: 1042 issue: 10 year: 2021 ident: CR8 article-title: Ischemic heart disease and rheumatoid arthritis—two conditions, the same background publication-title: Life doi: 10.3390/life11101042 contributor: fullname: Rezuş – volume: 51 start-page: 219 issue: 1 year: 2021 end-page: 229 ident: CR30 article-title: C-reactive protein and implications in rheumatoid arthritis and associated comorbidities publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2020.11.005 contributor: fullname: Choy – ident: CR7 – volume: 11 start-page: 13088 issue: 1 year: 2021 ident: CR25 article-title: Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure publication-title: Sci Rep doi: 10.1038/s41598-021-92488-2 contributor: fullname: Bellagambi – ident: CR41 – volume: 29 year: 2020 ident: CR23 article-title: NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: the getABI-study publication-title: IJC Heart Vasc doi: 10.1016/j.ijcha.2020.100553 contributor: fullname: Rudolf – volume: 15 start-page: 461 issue: 8 year: 2019 end-page: 474 ident: CR13 article-title: Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-019-0256-0 contributor: fullname: Ferguson – volume: 19 start-page: 1 issue: 1 year: 2017 end-page: 12 ident: CR27 article-title: Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1224-1 contributor: fullname: Pandya – ident: CR20 – volume: 388 start-page: 529 issue: 6 year: 2023 end-page: 542 ident: CR1 article-title: Rheumatoid arthritis—common origins, divergent mechanisms publication-title: N Engl J Med doi: 10.1056/NEJMra2103726 contributor: fullname: Firestein – volume: 45 start-page: 68 issue: 1 year: 2022 end-page: 74 ident: CR34 article-title: NT Pro-BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement publication-title: Clin Cardiol doi: 10.1002/clc.23760 contributor: fullname: Zhao – volume: 7 start-page: 19 year: 2020 ident: 6826_CR5 publication-title: Rheumatology and therapy doi: 10.1007/s40744-019-00189-0 contributor: fullname: DJ DeMizio – ident: 6826_CR41 doi: 10.1155/2017/5858315 – ident: 6826_CR7 doi: 10.1177/11795441211028751 – volume: 9 issue: 4 year: 2019 ident: 6826_CR24 publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026030 contributor: fullname: E-H Nah – volume: 259 start-page: 75 year: 2017 ident: 6826_CR31 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.02.003 contributor: fullname: Y Li – volume: 9 start-page: 754 year: 2018 ident: 6826_CR19 publication-title: Front Immunol doi: 10.3389/fimmu.2018.00754 contributor: fullname: NR Sproston – volume: 37 start-page: 257 issue: 2 year: 2010 ident: 6826_CR26 publication-title: J Rheumatol doi: 10.3899/jrheum.090769 contributor: fullname: WP Kuan – volume: 170 start-page: e472 issue: 6 year: 2019 ident: 6826_CR16 publication-title: Clin Ter contributor: fullname: S Paparo – ident: 6826_CR17 doi: 10.1038/s41440-020-0483-4 – volume: 31 start-page: 1095 issue: 6 year: 2004 ident: 6826_CR29 publication-title: J Rheumatol contributor: fullname: PH Dessein – volume: 88 start-page: 19 issue: 5 year: 2016 ident: 6826_CR36 publication-title: Ter Arkh doi: 10.17116/terarkh201688519-26 contributor: fullname: I Kirillova – volume: 6 issue: 1 year: 2020 ident: 6826_CR9 publication-title: RMD Open doi: 10.1136/rmdopen-2019-001032 contributor: fullname: P Błyszczuk – volume: 37 start-page: 909 year: 2018 ident: 6826_CR40 publication-title: Clin Rheumatol doi: 10.1007/s10067-017-3961-6 contributor: fullname: GA Rongen – ident: 6826_CR15 doi: 10.3389/fphar.2021.765768 – volume: 105 start-page: 409 issue: 9 year: 2005 ident: 6826_CR33 publication-title: J Am Osteopath Assoc contributor: fullname: MB Clearfield – volume: 11 start-page: 1042 issue: 10 year: 2021 ident: 6826_CR8 publication-title: Life doi: 10.3390/life11101042 contributor: fullname: E Rezuş – volume: 16 issue: 6 year: 2021 ident: 6826_CR37 publication-title: PLoS ONE doi: 10.1371/journal.pone.0253793 contributor: fullname: TH Nguyen – volume: 1 start-page: 598 issue: 7 year: 2021 ident: 6826_CR14 publication-title: Nature aging doi: 10.1038/s43587-021-00082-y contributor: fullname: N Sayed – ident: 6826_CR20 doi: 10.1016/j.semarthrit.2020.11.005 – volume: 12 start-page: 182 issue: 1 year: 2022 ident: 6826_CR18 publication-title: Diagnostics doi: 10.3390/diagnostics12010182 contributor: fullname: B Frade-Sosa – volume: 1 start-page: 207 issue: 3 year: 2003 ident: 6826_CR22 publication-title: Am Heart Hosp J doi: 10.1111/j.1541-9215.2003.02109.x contributor: fullname: JL Torres – volume: 43 start-page: 81 issue: 1 year: 2015 ident: 6826_CR28 publication-title: Allergol Immunopathol doi: 10.1016/j.aller.2013.11.003 contributor: fullname: AK Shrivastava – ident: 6826_CR38 doi: 10.1093/eurheartj/ehz745.0836 – ident: 6826_CR32 doi: 10.1093/rheumatology/kes279 – volume: 20 issue: 4 year: 2021 ident: 6826_CR6 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2021.102776 contributor: fullname: FA Figus – volume: 51 start-page: 219 issue: 1 year: 2021 ident: 6826_CR30 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2020.11.005 contributor: fullname: JE Pope – volume: 29 year: 2020 ident: 6826_CR23 publication-title: IJC Heart Vasc doi: 10.1016/j.ijcha.2020.100553 contributor: fullname: H Rudolf – volume: 41 start-page: 863 issue: 5 year: 2021 ident: 6826_CR3 publication-title: Rheumatol Int doi: 10.1007/s00296-020-04731-0 contributor: fullname: K Almutairi – volume: 11 start-page: 13088 issue: 1 year: 2021 ident: 6826_CR25 publication-title: Sci Rep doi: 10.1038/s41598-021-92488-2 contributor: fullname: FG Bellagambi – volume: 160 start-page: A257 issue: 4 year: 2021 ident: 6826_CR35 publication-title: Chest doi: 10.1016/j.chest.2021.07.265 contributor: fullname: L Kondrateva – volume: 39 start-page: 583 issue: 4 year: 2019 ident: 6826_CR12 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.118.312037 contributor: fullname: H Noels – volume: 15 start-page: 461 issue: 8 year: 2019 ident: 6826_CR13 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-019-0256-0 contributor: fullname: LD Ferguson – volume: 45 start-page: 68 issue: 1 year: 2022 ident: 6826_CR34 publication-title: Clin Cardiol doi: 10.1002/clc.23760 contributor: fullname: X Zhao – volume: 19 start-page: 1 issue: 1 year: 2017 ident: 6826_CR27 publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1224-1 contributor: fullname: JM Pandya – ident: 6826_CR11 doi: 10.32873/unmc.dc.gmerj.4.1.021 – volume: 4 issue: 7 year: 2009 ident: 6826_CR21 publication-title: PLoS ONE doi: 10.1371/journal.pone.0006242 contributor: fullname: J Graf – volume: 75 start-page: 706 issue: Suppl 2 year: 2016 ident: 6826_CR39 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-eular.4903 contributor: fullname: IG Kirillova – ident: 6826_CR42 doi: 10.21203/rs.3.rs-2868920/v1 – volume: 388 start-page: 529 issue: 6 year: 2023 ident: 6826_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMra2103726 contributor: fullname: EM Gravallese – ident: 6826_CR10 – volume: 9 start-page: 880 issue: 4 year: 2020 ident: 6826_CR2 publication-title: Cells doi: 10.3390/cells9040880 contributor: fullname: Y-J Lin – volume: 16 start-page: 361 issue: 7 year: 2020 ident: 6826_CR4 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-020-0428-y contributor: fullname: AG Semb |
SSID | ssj0002891 |
Score | 2.4473794 |
Snippet | Introduction
Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to... Cardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to its... IntroductionCardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to... INTRODUCTIONCardiovascular disease (CVD) is the most critical extra-articular manifestation of rheumatoid arthritis, and inflammatory molecules contribute to... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 137 |
SubjectTerms | Biomarkers Brain natriuretic peptide C-reactive protein Cardiovascular disease Cardiovascular diseases Chemokines Enzyme-linked immunosorbent assay Medicine Medicine & Public Health Original Article Pathogenesis Plasma Plasma levels Rheumatoid arthritis Rheumatology |
Title | CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis |
URI | https://link.springer.com/article/10.1007/s10067-023-06826-y https://www.ncbi.nlm.nih.gov/pubmed/38006573 https://www.proquest.com/docview/2911642287 https://search.proquest.com/docview/2893841377 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1BT9swFH4aRUJcGBswylhlJG4Q1Di2kxzbig5tUO3QSuUUObYjEFqKSnpgh_12nh2nBXU7cIuUPNuxv_f8kvfeZ4BTphOuDSpSnqdRwIquRp0z3YDlPNJoMpVitjj5ZiSuJuzHlE9Xddwu2b2JSDpD_arWDQ1rgFuMPSeFiuB5Aza5JfxqwWbv--3Py6UBpv6gvDi2JiZNfK3Mv1t5ux-tOZlrAVK37ww_wrip3qnTTR4uFlV-of6skzm-55V2Ycf7oaRXA-cTfDDlZ9i68ZH2Pfg7mA6uUyJLTUbjAHvvj36dE0nKWWWLrYjtj_gkL4IoRWD9dgF74mpR8MrJqjfprsSHg4gt-rd5QXMUJfM7s7Cy95ogju8cy9I-TIaX48FV4M9qCFQU8ypgaV7gxzQ1USTjWAgmmKPKT3CXVEaFvChCy3UjQyE0T9BvirsyTVJOuREhSh1Aq5yV5hBIkcpcI4C6KpWMSp4Lw0KpGcX2CqaiNpw1K5Y91pQc2Yp82U5phlOauSnNnttw3Cxq5tXzKaNo4oUlP4vbcLK8jYployWyNLMFPoOeXMIsIWMbvtRgWHYXJdZ1i3Eo583Krhr__1iO3vf4V9im6ELVP3yOoVXNF-YbukBV3kHID_v9UcdDvwMbE9p7Aart_gA |
link.rule.ids | 315,786,790,27955,27956,41114,41556,42183,42625,52144,52267 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT9swFH8arQRcYBsDunWbJ-02UjWJ7STHUsEKtBWHViqnyLEdgRApKumhHPjbeU6clsJ24BYpfrZjvy_nvfczwG-qQqY0ClKSRL5D07ZCmdNthybMV6gypaSmOHkw5L0xPZ-wiS0Ke6iy3auQZKGpXxS7oWZ10MaYi1I87iw2oE6Nha9BvfP36uJkqYE9e1NeEBgdE4W2WObfvawbpDde5psIaWF4TndhXE25zDe5bc3zpCUfX6E5vvebPsKO9URJp2SdT_BBZ59hc2Bj7Xvw1J10-xERmSLDkYPDHw8vj4gg2TQ35VbEjEdsmhdBPkXWuitC9qSoRsGnglauJbwSGxAipuzfZAbNkJTMrvXc0N4ogpx8XeAsfYHx6cmo23PsbQ2O9AOWOzRKUjxOe9r3RRBwTjktwPJDtJNSS5elqWvQboTLuWIhek5BW0RhxDymuYtU-1DLppk-BJJGIlHIQm0ZCeoJlnBNXaGoh_2lVPoN-FNtWXxfgnLEK_hls6QxLmlcLGm8aECz2tXYCuhD7KGS5wb-LGjAr-VrFC0TLxGZns6xDfpyITWQjA04KLlhOZwfGuctwKkcVTu76vz_c_n6vuY_Yas3GvTj_tnw4htse-hQlb9_mlDLZ3P9HR2iPPlh-f8Zr6n_bw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZgSIgL4s14BokbVKxpkrbHMZh4ThyYtFuVNqnGgQ6N7sCF346ddgMEHLhVauymsWO7tf0F4FiYSBqLGylN48ATecvgnrMtT6QyMGgys0xQc_J9T131xc1ADr508btq92lKsuppIJSmojx7MfnZl8Y3tLIe-hs6NIUr720eFsg1ko73eXtmi3l9Zl4YkrWJo7pt5nce313Tj3jzR67UuaDuCizXsSNrV8JehTlbrMHifZ0dX4f3zqBzFzNdGNZ79JDzee_hlGlWjEpqkGL01qwuzGKoWagMzy7Jzlz_CF452uxbiSqrUziMGvWplmeMpGw8tBOifTIMdW_okJE2oN-9fOxcefX5Cl4WhLL0RJzm-AHMbRDoMFRKKOHg7SP0bJnNfJnnPuHTaF8pIyOMdcKWjqNYcmmVj1Sb0ChGhd0Glsc6NSj0VhZrwbVMlRW-NoIjv1xkQRNOpkubvFQwGsknYDIJIkFBJE4QyVsT9qarn9Rb6jXhaJYVAZaFTTia3cbNQBkOXdjRBMdg9BUJAlFswlYltdnjgojCrRCncjoV4yfzv-ey87_hh7D4cNFN7q57t7uwxDECqv7X7EGjHE_sPkYwZXrglPQDucDmeg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCL9+and+NT-proBNP%2C+a+notable+link+between+inflammatory+mediator+and+cardiovascular+disease+biomarker+in+rheumatoid+arthritis&rft.jtitle=Clinical+rheumatology&rft.au=Shamsi%2C+Afsaneh&rft.au=Roghani%2C+Seyed+Askar&rft.au=Soufivand%2C+Parviz&rft.au=Pournazari%2C+Mehran&rft.date=2024-01-01&rft.pub=Springer+International+Publishing&rft.issn=0770-3198&rft.eissn=1434-9949&rft.volume=43&rft.issue=1&rft.spage=137&rft.epage=145&rft_id=info:doi/10.1007%2Fs10067-023-06826-y&rft.externalDocID=10_1007_s10067_023_06826_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0770-3198&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0770-3198&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0770-3198&client=summon |